Physician profile
David A Friedman
NPI 1285781948
$3,687.30
in general payments reported to CMS, 2019-2025
25 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $291 · 2024: $2,162 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537 · Consulting Fee: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.30 |
| Consulting Fee | $1,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,372.57 | 2024 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $410.75 | 2024-2025 | |
| Novo Nordisk INC | $335.72 | 2024-2025 | Wegovy, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $194.88 | 2024-2025 | |
| Medtronic, INC. | $170.98 | 2023 | Cobalt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.01 | 2023-2025 | Jardiance, Synjardy |
| Heartflow, INC. | $140.43 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.77 | 2024-2025 | Farxiga, Wainua |
| Cochlear Americas | $121.48 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Takeda Pharmaceuticals U.S.A., INC. | $101.92 | 2025 | Entyvio |
| Edwards Lifesciences Corporation | $96.47 | 2025 | Sapien 3 Ultra Resilia |
| Medicomp INC | $90.61 | 2024-2025 | Telepatch Cardiac Monitor |
| Astellas Pharma US INC | $58.61 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $56.50 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Amgen INC. | $40.65 | 2025 | Repatha, Otezla |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $25.04 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $23.79 | 2025 | |
| Celltrion USA INC. | $22.71 | 2025 | Vegzelma |
| Glaxosmithkline, LLC. | $22.40 | 2025 | Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $21.56 | 2025 | Gemtesa |
| Philips North America LLC | $21.01 | 2024 | (Ck7) Extended Holter |
| Mannkind Corporation | $18.45 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $17.40 | 2025 | Rhythm Express |
| Esperion Therapeutics, INC. | $16.98 | 2024 | Nexletol |
| Inspire Medical Systems, INC. | $16.61 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.